Sudarshan Pharma Industries Limited

Equities

SUDARSHAN

INE00TV01015

Pharmaceuticals

Market Closed - Bombay S.E. 11:00:58 08/07/2024 BST 5-day change 1st Jan Change
86 INR +0.01% Intraday chart for Sudarshan Pharma Industries Limited +6.81% +5.79%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sudarshan Pharma Industries Gets Board Nod for Convertible Warrant Issue MT
Sudarshan Pharma Industries Limited announced a financing transaction CI
Sudarshan Pharma Industries Limited Appoints Nirav Shah as the Company Secretary, Effective June 1, 2024 CI
Sudarshan Pharma Industries Limited Announces Resignation of Ishita Samani as Company Secretary and Compliance Officer CI
1,165,368 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 30-MAR-2024. CI
11,224,937 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 29-MAR-2024. CI
Sudarshan Pharma Industries Limited Appoints Sachin Mehta as the Chief Financial Officer, Effective December 12, 2023 CI
Sudarshan Pharma Industries Limited Announces Resignation of Nilesh Thakkar as Additional Director CI
Sudarshan Pharma Industries Limited Announces Board Changes CI
Sudarshan Pharma Industries Limited Announces Resignation of Mr. Dharam Jilka from the Position of Chief Financial Officer with Effect from September 15, 2023 CI
Sudarshan Industries Limited Announces Intimation for Incorporation of A Subsidiary Company CI
Sudarshan Pharma Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Sudarshan Pharma Industries Limited signed a definitive agreement to acquire Ratna Lifesciences Pvt Ltd for INR 55 million. CI
Sudarshan Pharma Industries to Consider Acquisition of Ratna Lifesciences as Unit CI
Sudarshan Pharma Industries Limited Recommends Dividend for the Financial Year 2022-23, Payable on and from September 05, 2023 CI
Sudarshan Pharma Industries Limited Appoints Mr. Rushabh P Patil as Additional Director CI
Sudarshan Pharma Industries Limited Announces Resignation of RAJESH CHANDRAKUMAR HEDAOO as Director CI
Sudarshan Pharma Industries Limited has completed an IPO in the amount of INR 501.072 million. CI
Sudarshan Pharma Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Sudarshan Pharma Industries Limited has filed an IPO. CI
Chart Sudarshan Pharma Industries Limited
More charts
Sudarshan Pharma Industries Limited is an India-based company, which is engaged in job work manufacturing in pharmaceutical items and traders in chemicals and solvents in India. The Company operates in the State of Maharashtra, Gujarat, Himachal Pradesh, and Uttarakhand. The Company is involved in specialty chemicals and intermediates for pharma, agriculture chemicals, coating, paints, adhesive, and various other industries. It is also into active pharmaceuticals ingredients manufacturing. It is also into specialty chemicals imports and exports, as well as supply of same to the actual users. The Company provides customize specialty chemicals to its clients in India and abroad regularly. The Company is also involved in contract manufacturing, outsource and supply of generic pharma formulation, and medicines to healthcare institution, government, non-governmental organization (NGO) and hospitals.
More about the company
  1. Stock Market
  2. Equities
  3. SUDARSHAN Stock
  4. News Sudarshan Pharma Industries Limited
  5. Sudarshan Pharma Industries Gets Board Nod for Convertible Warrant Issue